BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26621074)

  • 1. Assessing the dermal compatibility of a new female incontinence product line.
    Gutshall D; Zhou S; Wang B; Farage MA; Hochwalt AE
    Cutan Ocul Toxicol; 2016 Dec; 35(4):287-95. PubMed ID: 26621074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal safety assessment of Arm & Hammer laundry products formulated for sensitive skin.
    Frederick DM; Vorwerk L; Gupta A; Ghassemi A
    Cutan Ocul Toxicol; 2017 Sep; 36(3):263-272. PubMed ID: 28073339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of modifications of the traditional patch test in assessing the chemical irritation potential of feminine hygiene products.
    Farage MA; Meyer S; Walter D
    Skin Res Technol; 2004 May; 10(2):73-84. PubMed ID: 15059174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a sensitive test method to evaluate mechanical irritation potential on mucosal skin.
    Farage MA; Meyer S; Walter D
    Skin Res Technol; 2004 May; 10(2):85-95. PubMed ID: 15059175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Behind-the-Knee test: an efficient model for evaluating mechanical and chemical irritation.
    Farage MA
    Skin Res Technol; 2006 May; 12(2):73-82. PubMed ID: 16626379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the behind-the-knee clinical test be used to evaluate the mechanical and chemical irritation potential for products intended for contact with mucous membranes?
    Farage MA; Miller KW; Ledger WJ
    Curr Probl Dermatol; 2011; 40():125-132. PubMed ID: 21325847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological testing of an improved apertured film surface for feminine hygiene pads.
    Farage MA; Wang B; Tucker H; Ogle J; Rodenberg C; Azuka CE; Klebba C; Wilhelm KP
    Cutan Ocul Toxicol; 2012 Sep; 31(3):198-203. PubMed ID: 22141375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population.
    Farage MA; Maibach H
    Cutan Ocul Toxicol; 2007; 26(1):37-43. PubMed ID: 17464747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative irritation patch test of sanitary pads on sensitive skin.
    Farage M; Stadler A
    J Cosmet Dermatol; 2005 Sep; 4(3):179-83. PubMed ID: 17129263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatological testing of an emollient-treated menstrual pad with a novel foam absorbent core.
    Farage MA; Segarra VS; Bramante M; Elsner P; Maibach HI
    Cutan Ocul Toxicol; 2008; 27(4):333-43. PubMed ID: 19037765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new test for mechanical irritation: behind the knee as a test site.
    Farage MA; Gilpin DA; Enane NA; Baldwin S
    Skin Res Technol; 2001 Aug; 7(3):193-203. PubMed ID: 11554707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating lotion transfer from products to skin using the behind-the-knee test.
    Farage MA
    Skin Res Technol; 2010 May; 16(2):243-52. PubMed ID: 20456105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the dermal safety of products intended for genital mucosal exposure.
    Farage MA; Scheffler H
    Curr Probl Dermatol; 2011; 40():116-124. PubMed ID: 21325846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial comparing skin health effects and comfort of two adult incontinence protective underwear.
    Trowbridge MM; Wang B; Gutshall D; Rodenberg CA; Farage MA
    Skin Res Technol; 2017 May; 23(2):202-211. PubMed ID: 27500487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Irritation and Sensitization Potential of Eight Baby Skin Care Products.
    Galzote C; Thomas M; Sachdev M
    J Drugs Dermatol; 2016 Oct; 15(10):1244-1248. PubMed ID: 27741343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific dermatological benefits associated with quantities of lotion transferred to the skin.
    Farage MA; Esquerra J; Cheng R; Carpenter S; Bunasky K; Gutshall D; Lawrence A; Messerschmidt A
    J Cosmet Dermatol; 2018 Oct; 17(5):900-910. PubMed ID: 29094461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a measure of acute irritation to predict the outcome of repeated usage of hand soap products.
    Williams C; Wilkinson M; McShane P; Pennington D; Fernandez C; Pierce S
    Br J Dermatol; 2011 Jun; 164(6):1311-5. PubMed ID: 21332456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of damaged skin barrier induced by subclinical irritation on the sequential irritant contact dermatitis.
    Yan-yu W; Xue-min W; Yi-Mei T; Ying C; Na L
    Cutan Ocul Toxicol; 2011 Dec; 30(4):263-71. PubMed ID: 21774626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.